AVE9633

AVE9633 Uses, Dosage, Side Effects, Food Interaction and all others data.

AVE9633 is an anti-CD33 monoclonal antibody-DM4 conjugate.

An immunoconjugate consisting of the humanized monoclonal antibody huMy9-6 conjugated to the cytotoxic maytansinoid derivative DM4 with potential antineoplastic activity. The monoclonal antibody portion of anti-CD33 monoclonal antibody-DM4 conjugate AVE9633 specifically binds to the cell surface antigen CD33 expressed on myeloid leukemia cells; upon internalization, the DM4 moiety is released, binds tubulin, and disrupts microtubule assembly/disassembly dynamics, resulting in the inhibition of cell division and cell growth in myeloid leukemia cells that express CD33. CD33 is expressed on normal non-pluripotent hematopoietic stem cells as well as on myeloid leukemia cells.[National Cancer Institute Drug Dictionary]

Trade Name AVE9633
Generic AVE9633
Type
Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: September 19, 2023 at 7:00 am
AVE9633
AVE9633

Uses

Investigated for use/treatment in leukemia (myeloid).

Innovators Monograph

You find simplified version here AVE9633


*** Taking medicines without doctor's advice can cause long-term problems.
Share